NCT05276856
Recovery Rate in Secondary Hypothyroidism
StatusActive, Not Recruiting
PhaseNot specified
SponsorNova Scotia Health Authority
Primary completion (estimated)
At risk: Primary completion moved 2 years later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Dec 31, 2025 to Dec 31, 2027 Show 6 more changesShow less
- Eligibility criteria expanded, about 5 words
- Trial status changed: Unknown → Active, Not Recruiting
- Study completion pushed from Dec 31, 2025 to Dec 31, 2028
- Study description expanded, about 9 words
- Site details revised
- Publications: details revised at 6 of 6 entries
- Minor Changed Registry marked status Unknown; last known: Recruiting
- Notable Primary and study completion dates pushed to Dec 31, 2025
- Trial status: Not Yet Recruiting to Unknown
- Study sites: 0 to 1
- Start date changed from estimate of Mar 10, 2022 to Apr 4, 2022
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Percentage of patients achieving euthyroid status
Timeframe: 12 weeks
Arms and interventions
Drugs: Levothyroxine
Sites
1 site in 1 country
- Nova Scotia HealthHalifax, Canada